CIP
OXFD

Cornerstone Investment Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Cornerstone Investment Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,531
Closed -$175K – 240
2019
Q4 		$175K Buy
+10,531
New +$171K 0.01% 175

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Cornerstone Investment Partners's OXFD Position: Q1 2020 in Review

Cornerstone Investment Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2020, closing a stake of 10,531 shares — an estimated $175K sold.

Cornerstone Investment Partners first reported a position in OXFD in Q4 2019 and held it in 1 quarter. The position peaked at $175K in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q1 2020.

  • Cornerstone Investment Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Cornerstone Investment Partners sold 10,531 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2020, an estimated $175K.
  • Cornerstone Investment Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2019 and held it in 1 quarter.
  • Cornerstone Investment Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $175K in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2020.

Based on Cornerstone Investment Partners's 13F filing for Q1 2020, filed 27 Apr 2020.